Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

Novo Nordisk (NYSE: NVO) has announced sweeping price cuts for its blockbuster GLP-1 drugs, Wegovy and Ozempic, offering ...

In summary, under the Trump plan, the U.S. health system continues to fail Americans — by not viewing obesity as a disease, ...

Discover Donald Trump's revolutionary initiative to reduce the cost of obesity drugs to as low as $149, making weight loss ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media ...

Most analysts predict the market for new weight loss drugs such as Wegovy and Mounjaro will be enormous, but estimates vary for its exact size depending on who you ask. Stream NBC 5 for free, 24/7, ...

Taking Ozempic or Wegovy? Yale just dropped a bombshell: two glasses of wine now hit like four, your BAC climbs higher and ...

For 25 years, I’ve served as a rehabilitation counselor for the deaf at MassAbility, a state agency that helps individuals with disabilities find employment and live independently. I’m also the ...

The Philippine Food and Drug Administration (FDA) has recently approved tirzepatide, a diabetes and anti-obesity drug, according to the FDA site.

"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...